Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2019

Segment Reporting [Abstract]

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying unaudited condensed consolidated statements of operations is as follows (in millions, except percentages):

	Three Months Ended March 31,
	2019			2018
Net sales
MedSurg	$	766		$	711
Rhythm and Neuro	757			736
Cardiovascular	972			933
	$	2,493		$	2,379
	Three Months Ended March 31,
	2019			2018
Income (loss) before income taxes
MedSurg	$	256		$	259
Rhythm and Neuro	155			153
Cardiovascular	275			290
Operating income of reportable segments	686			703
Corporate expenses, including hedging activities	(48		)	(100		)
Intangible asset impairment charges, acquisition-related, restructuring- and restructuring-related and litigation-related net (charges) credits	63			(54		)
Amortization expense	(160		)	(141		)
Operating income (loss)	541			407
Other expense, net	(84		)	(84		)
Income (loss) before income taxes	$	457		$	323
	Three Months Ended March 31,
	2019			2018
Reportable segment operating income as a percentage of reportable segment net sales
MedSurg	33.4		%	36.4		%
Rhythm and Neuro	20.5		%	20.8		%
Cardiovascular	28.3		%	31.1		%